Loading...

Molecular Partners AG

MLLCF•PNK
Healthcare
Biotechnology
$2.50
$0.00(0.00%)
U.S. Market opens in 3h 21m

Molecular Partners AG (MLLCF) Stock Overview

Explore Molecular Partners AG’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap93.5M
P/E Ratio-1.20
EPS (TTM)$-2.10
ROE-0.60%
Fundamental Analysis

AI Price Forecasts

1 Month$2.38
3 Months$3.05
1 Year Target$2.57

MLLCF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Molecular Partners AG (MLLCF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.61, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $2.57.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.20 and a market capitalization of 93.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
11.11%
3-Month Change
11.11%
6-Month Change
-30.56%
Year-to-Date (YTD) Change
-28.57%
1-Year Change
-40.76%
3-Year Change
-62.46%
5-Year Change
-89.81%
All-Time (Max) Change
-88.95%

Contact Information

https://www.molecularpartners.com
41 44 755 77 00
Wagistrasse 14, Schlieren, NaN, 8952

Company Facts

158 Employees
IPO DateJun 14, 2018
CountryCH
Actively Trading

Frequently Asked Questions